Bloomberg Businessweek Weekend - April 21st, 2023
Bloomberg Businessweek
00:00
The Relationship Between Weight Watchers and Telemedicine
SEMA: Is it a case of thinking about current WW members getting into weight loss drugs or that the telemedicine company ultimately will help you attract more WW customers? Seemie: We looked at over 30 different startups and landed on sequence because they have built a tech stack better than anyone else. SEMA: There is a bit of a controversy around O'Zembix. So I'm curious if you can share with us and our listeners what is your criteria around prescribing it?Seemie: When people are looking for clinical intervention, and the benefit of the combination with Weight Watchers is when it is not medically appropriate.
Play episode from 18:21
Transcript
